Christopher Ott's Biography

Christopher Ott, Research Fellow, Harvard School of Public Health

Dr. Christopher Ott received his PhD in molecular genetics from Northwestern University, where he studied the molecular mechanisms of transcriptional regulation of CFTR, mutations in which cause cystic fibrosis. He is currently a Leukemia & Lymphoma Society Research Fellow in the laboratory of Dr. James Bradner at Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA. His research focuses on the development of synthetic inhibitors of transcriptional regulatory proteins and their potential use as cancer therapeutics.